Research and development - Press Releases

Date	Title	Company
29-Aug-2023	Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries	Elekta
29-Aug-2023	The Art of Neuroscience: Synaptic Transmission and Plasticity in Isolated Neurons	PR&D
29-Aug-2023	Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-INAD for the Treatment of Infantile Neuroaxonal Dystrophy (INAD) and Announces Upcoming Type B Pre-IND Meeting with the U.S. FDA	Bloomsbury Genetic Therapies Limited
29-Aug-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer	HUTCHMED
29-Aug-2023	Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines	CSL Vifor
29-Aug-2023	Novartis presents new long-term Leqvio®▼ (inclisiran) data demonstrating consistent safety profile and efficacy beyond six years	Novartis
29-Aug-2023	KEY HUMAN BLADDER CANCER GENES PINPOINTED IN CATS AND DOGS	Wellcome Sanger Institute
29-Aug-2023	UEA researchers develop new tool to reduce stroke risk	University of East Anglia
29-Aug-2023	Exploring New Frontiers in Drug Delivery: CD Formulation Introduces State-of-the-Art Microsphere and Microneedle Technologies	CD Formulation
28-Aug-2023	CD Formulation Empowers High-volume Manufacturing of Microspheres	CD Formulation
28-Aug-2023	Alfa Chemistry Catalysts Releases Photocatalysts for Varieties of Applications	Alfa Chemistry
28-Aug-2023	Alfa Chemistry Launches a New Blog Section: Sharing Chemical Uses, Chemistry Information and News	Alfa Chemistry
23-Aug-2023	Pharmaceutical Analytical Service at Alfa Chemistry Testing Lab Fuels Drug R&D	Alfa Chemistry Testing Lab
23-Aug-2023	Alfa Chemistry Offers Fluorinated Building Blocks for Material, Medicinal, Agricultural, Organic Chemistry Research	Alfa Chemistry
22-Aug-2023	Wellcome grants €2.4 million to RCSI researcher to advance research on deprescribing medicines using big data	RCSI University of Medicine and Health Sciences
22-Aug-2023	Actimed Therapeutics secures additional £4.75m funding in Series A extension round, almost doubling Series A proceeds	Actimed Therapeutics Ltd
22-Aug-2023	Qlucore recognized by strategic innovation program for MedTech	Qlucore
22-Aug-2023	Cherwell to advise on reducing risk with EM in aseptic processing	Cherwell
22-Aug-2023	Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C (NPC)	Bloomsbury Genetic Therapies Limited
22-Aug-2023	Young women most likely to have PTSD of all demographics and more likely than members of the Armed Forces	Clerkenwell Health